LUPO, Luigi Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 4.784
EU - Europa 1.507
AS - Asia 699
SA - Sud America 6
OC - Oceania 5
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.007
Nazione #
US - Stati Uniti d'America 4.765
CN - Cina 452
DE - Germania 341
SE - Svezia 313
UA - Ucraina 192
SG - Singapore 183
IT - Italia 179
RU - Federazione Russa 131
FI - Finlandia 118
GB - Regno Unito 101
FR - Francia 64
IN - India 25
BE - Belgio 24
CA - Canada 17
IR - Iran 15
NL - Olanda 15
IE - Irlanda 10
AU - Australia 5
MK - Macedonia 4
TR - Turchia 4
VN - Vietnam 4
BR - Brasile 3
PL - Polonia 3
RO - Romania 3
CL - Cile 2
EG - Egitto 2
EU - Europa 2
GE - Georgia 2
ID - Indonesia 2
JP - Giappone 2
KZ - Kazakistan 2
TM - Turkmenistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
EE - Estonia 1
ES - Italia 1
HK - Hong Kong 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KR - Corea 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
Totale 7.007
Città #
Fairfield 587
Chandler 505
Jacksonville 447
Woodbridge 401
Ashburn 320
Cambridge 261
Nyköping 258
Houston 242
Seattle 232
Ann Arbor 226
Wilmington 226
Singapore 145
Lawrence 110
Roxbury 109
Nanjing 100
Beijing 90
Des Moines 76
Boardman 60
New York 51
Princeton 48
Shenyang 46
Bari 45
Inglewood 42
Jiaxing 33
San Diego 28
Brooklyn 27
Nanchang 25
Brussels 24
Dearborn 24
Eboli 22
Los Angeles 22
Marseille 21
Tianjin 20
Hebei 17
Paris 16
Santa Clara 16
Helsinki 15
Redwood City 15
San Francisco 15
Toronto 15
Changsha 14
London 14
Ardabil 12
Augusta 11
Guangzhou 11
Munich 11
Dublin 10
Falls Church 9
Leawood 9
San Mateo 9
Hangzhou 8
Jinan 8
Norwalk 8
Pune 8
Washington 8
Grafing 7
Shanghai 7
Zhengzhou 7
Auburn Hills 6
Amsterdam 5
Mola Di Bari 5
Mumbai 5
Ningbo 5
Rome 5
Taizhou 4
Turin 4
Frankfurt am Main 3
Fuzhou 3
Hefei 3
Kilburn 3
Monmouth Junction 3
Sydney 3
Altamura 2
Ashgabat 2
Baotou 2
Bisceglie 2
Bitola 2
Cairo 2
Castel Maggiore 2
Esanatoglia 2
Florence 2
Fossano 2
Groningen 2
Indiana 2
Islington 2
Kunming 2
Marano Di Napoli 2
Molfetta 2
Montreal 2
Novokuznetsk 2
Nürnberg 2
Palermo 2
Pisa 2
Pittsburgh 2
Qingdao 2
Romola 2
Shenzhen 2
Skopje 2
Stimigliano 2
Tappahannock 2
Totale 5.266
Nome #
NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC 132
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts 122
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients 115
Targeting angiogenesis in biliary tract cancers: An open option 115
Protective colostomy closure: the hazards of a "minor" operation 111
TROMBOPOIETINA E PIASTRINOPENIA NEI PAZIENTI SOTTOPOSTI A TRAPIANTO DI FEGATO (OLT):RISULTATI PRELIMINARI SU 21 PAZIENTI 110
Improved accuracy of computed tomography in local staging of rectal cancer using water enema 108
Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma 104
Reliability of clinical judgement in evaluation of the nutritional status of surgical patients 100
Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma 99
Radiofrequency ablation of HCC on liver cirrhosis. Evaluation of effect by spiral-CT and pathology on native livers of trasplanted patients 98
D-MELD, a strong and accurate tool to guide Donor -2- Recipient Matching 95
Is pyloric function preserved in pylorus-preserving pancreaticoduodenectomy? 94
Lipoprotein(a), lipids and proinflammatory cytokines in patients undergoing major abdominal surgery 89
Prediction of mortality by logistic regression analysis in patients with postoperative enterocutaneous fistulae. 89
null 86
Randomized clinical trial of radiofrequency-assisted versus clamp-crushing liver resection 82
null 81
MELD predictive value of alterations of brain perfusion during liver transplantation 80
Facing HCV recurrence after liver transplantation: antiviral therapy response and clinical out come 80
Resection vs radiofrequency ablation for HCC from 3 to 5 cm: A single centre experience on 101 child- pugh class A-B naive patients 79
Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? 79
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 79
Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial 77
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C. 77
null 76
Accuratezza diagnostica dello staging dell’HCC nei pazienti con cirrosi: la lezione dei trapianti di fegato 73
Elective versus emergency full thickness rectal prolapse treatment using a perineal approach - a video vignette 73
Plasma concentrations but not serum concentrations of brain-derived neurotrophic factor are related to pro-inflammatory cytokines in patients undergoing major abdominal surgery 72
Tempo di ischemia fredda e produzione di trombopoietina(TPO) nel trapianto ortotopico di fegato: risultati preliminari su 21 casi 71
Laparoscopic management of neuroendocrine tumors: State-of-the-art 71
A national mandatory-split liver policy: A report from the Italian experience 71
null 70
RECTAL-CARCINOMA - CT STAGING WITH WATER AS CONTRAST-MEDIUM 69
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis 69
Solutions for organ perfusion and storage: haemorheologic aspects 68
A Bayesan methodology to improve of early graft loss after liver transplantation derived from the Liver Match study 68
State of lucid delirium after orthotopic liver transplantation. Clinical case 67
THE UN-SUSTAINABLE MATCH IN HCV LIVER TRANSPLANT PATIENTS 67
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial 66
Behind D-MELD :the role of primary indication (HCV or HBV) as significant Covariate in the Outcome Prediction after Liver Transplant 65
TROMBOPOIETINA (TPO) E TROMBOCITOPENIA NEI PAZIENTI SOTTOPOSTI A TRAPIANTO DI FEGATO: STUDIO PRELIMINARE SU 9 CASI 64
null 63
STATE OF LUCID DELIRIUM AFTER ORTHOTOPIC LIVER TRANSPLANTATION 62
LIVER RELATED EVENTS (LRE) IN PATIENTS WITH ESTABLISHED HCV RECURRENT DISEASE AFTER LIVER TRANSPLANTATION COULD BE PREDICTED BY LIVER STIFFNESS MEASUREMENT (LSM). 62
Increased in vitro and in vivo generation of procoagulant activity (tissue factor) by mononuclear phagocytes after Intralipid infusion in rabbits 61
Hepatocellular carcinoma progression is accelerated by cancer associated fibroblasts stimulated by tumor production of lysophosphatidic acid 61
Radiofrequency ablation of HCC on liver cirrhosis. Evaluation of effect by spiral-CT and pathology on native livers of trasplanted patients 61
Safe use of Grafts from HBcAb Positive Donors in Liver Transplantation -Analysis of Matching and Outcome 60
Liver Match, a prospective observational cohort study on liver transplantation in Italy: Study design and current practice of donor-recipient matching 60
Prognostic Value of Neutrophil/Lymphocyte Ratio in Liver Transplantation for HCC 59
Postoperative changes in serum interleukin-2 concentrations 59
The tumor microenvironment regulates HCC growth rate 59
ACUTE PANCREATITIS AFTER ORTOTOPIC LIVER TRANSPLANTATION 58
Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC 57
D-MELD, a powerful Instrument to Optimize Donor -2-Recipient Match.Differences betweenUS and Italy 57
Manuale di Metodologia della Ricerca ClinicA 56
EFFECT OF PERIOPERATIVE WHOLE BLOOD VS LEUCOCYTE-DEPLETED BLOOD TRANSFUSION ON SURVIVAL AFTER CURATIVE SURGERY FOR COLORECTAL 56
Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage 56
Reduction of postoperative immunosuppression with ranitidine in patients with cancer of the stomach or large bowel 55
Terapia fibrinolitica nel trattamento delle ulcere venose post-flebitiche 54
Tempo di ischemia fredda e produzione di trombopoietina(TPO)nel trapianto ortotopico di fegato (OLT): studio preliminare sui primi 9 casi. 54
OPTIMIZATION OF DONOR-RECIPIENT MATCH AND IDENTIFICATION OF THE FUTILE MATCH CUTOFF. A NATIONAL ITALIAN STUDY ON LIVER TRANSPLANTATION. 54
TROMBOPOIETINA E PIASTRINOPENIA NEI PZ. SOTTOPOSTI A TRAPIANTO DI FEGATO(OLT): RISULTATI PRELIMINARI SU 21 PZ 53
Platelets and hepatocellular cancer: Bridging the bench to the clinics 53
Limited prognostic value of staging systems for hepatocellular carcinoma on cirrhosis 52
null 51
Irisin improves the secretory defects of pancreatic islets from type 2 diabetic subjects 51
Down-staging in Liver Transplantation for HCC 50
RUOLO DEL TIPO DI PERFUSIONE NEL PRELIEVO DI FEGATO A SCOPO DI TRAPIANTO 50
Azione della pentossifillina sulla evoluzione in guarigione delle ferite sperimentali nel coniglio 49
Role of perioperative parenteral nutrition in patients submitted to curative surgery for gastric carcinoma. 49
Reliability and accuracy of the hepatic perfusion index as a diagnostic test for liver metastases. 48
Laminin-5 stimulates hepatocellular carcinoma growth through a different function of alpha 6 beta 4 and alpha 3 beta 1 integrins 48
PI3K class 1B controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma 48
Worse Graft Survival in HCV-Infected Transplanted Females Receiving a Male Donor Graft. The Liver Match Study 47
STUDIO DELL'MCP-1 (MONOCYTE CHEMOATTRACTANT PROTEIN) NEL TRAPIANTO DI FEGATO 47
Basiliximab vs Steroids in liver transplantation immunosuppression. A prospective randomized clinical trial. 46
Liver transplantation with hepatitis B core antibodypositive graft under hepatitis b Immunoglobulin and lamivudine prophilaxis 46
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment 46
Evaluation of RFA of HCC in patients underwent LTx: Spiral-CT and Pathology on native livers 45
[Blood flow assessment with Doppler color ultrasonography in primary and secondary tumors of the liver]. FT Valutazioni flussimetriche con eco color Doppler nei tumori epatici primitivi e secondari. 44
Fattori prognostici nel trattamento sclerosante delle varici esofagee sanguinanti: Studio preliminare 44
null 43
Anatomical hepatic resection using radiofrequency thermoablation in the treatment of primary or secondary liver tumors 43
null 43
HSP70 and VEGF blood levels in patients with hepatocellular carcinoma (HCC) 42
Valutazione prognostica delle fistole enterocutanee post operatorie: confronto fra due sistemi prognostici 42
Down-Staging in Liver Transplatation for HCC. Audit of an Experience 42
Hepatitis B-core antibody positive donors in Liver Trasplantation and their impact on graft survival:Evidence from the Liver Match cohort study 42
null 41
Reliability of clinical judgement in evaluation of the nutritional-status of surgial patients. 41
null 40
Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosi in 961 patients 40
Post-surgical trauma acute inflammation. A molecular analysis 39
Risk of seeding and metastasis in the thoracic or abdomianl wall due to RFA and biopsy of HCC on cirrhosis.Single centre experience. Cutionary note 39
Resection vs radiofrequency ablation for HCC from 3 to 5cm: A single centre experience on 101 child-pugh class A-B naive patients 39
Reliable Steroid-Free Immunosuppression in Liver Transplantation 36
Liver Transplantation vs Resection for patients with HCC within Milan Criteria 36
Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332/α3 integrin axis recovery of focal adhesion kinase ubiquitination 36
Totale 6.436
Categoria #
all - tutte 32.533
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.533


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020957 0 0 0 0 0 109 197 138 203 117 158 35
2020/20211.011 111 52 95 52 103 46 92 53 119 120 107 61
2021/2022854 20 133 10 47 22 50 41 52 39 38 138 264
2022/20231.350 182 120 84 118 162 196 18 154 245 7 33 31
2023/2024408 33 81 24 36 38 94 21 23 0 6 11 41
2024/2025475 22 22 159 44 58 170 0 0 0 0 0 0
Totale 7.116